Navigation Links
Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office
Date:8/21/2012

BOSTON, Aug. 21, 2012 /PRNewswire/ -- Sequence, Inc. and PCI, LLC, leaders in the fields of regulatory compliance and pharmaceutical calibration respectively, have announced the collaborative opening of a new office in the Innovation District of Boston, Massachusetts.

Establishing a Boston office provides Sequence and PCI an opportunity to extend service offerings to new and existing clients in the New England biotech and pharmaceutical sectors. "The coupling of validation and calibration services presents our clients with a streamlined approach to quality. It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike.  We are proud to partner with PCI, a firm well known as the distinguished leader in calibration services," said Mike Putnam, President of Sequence, Inc.

"For some time now, a New England presence has been a key part of our expansion plans," said Andy Ferrell, President of PCI. "We believe our services will be of great value to this region's life science community. Partnering with a validation firm that has high moral standards and values similar to ours is very attractive. We look forward to partnering with Sequence, Inc. and see this as a great opportunity for our firms to offer comprehensive, highly valued service solutions."

About Sequence, Inc.

Sequence, Inc. is proud to be celebrating its ten-year anniversary of providing validation and regulatory compliance services to the life sciences industry. Our areas of expertise include validation of laboratory instruments, information systems, and manufacturing equipment/processes as well as quality remediation, system configuration, and project management. We take pride in developing partner-like relationships with our clients and view employees as our most valuable asset.

About PCI, LLC.

PCI specializes in delivering instrument and equipment solutions that will reduce costs and enhance operational efficiencies while improving the compliance. Since 1996, our mission has been to provide personalized customer service, exceptional technical expertise, quality documentation and the integrity and ingenuity that our clients have grown to expect from the industry leader in calibration services.

For further information, visit www.sequencevalidation.com or email info@sequencevalidation.com for Sequence, Inc. and visit www.pci-llc.com or email PCI@pci-llc.com for PCI, LLC.

Contact:

Sequence, Inc.
Mike Putnam
919-844-7171

PCI, LLC
Andy Ferrell, President 
877-724-2257

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE Sequence, Inc.; PCI, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (United States, China, Japan, Brazil, United Kingdom, Germany, France, ... Surgical Procedure Volumes: ... provides surgical procedure volume data in a geographic context. ... analysis of growth drivers and inhibitors, including world population ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... , ... The temporary closing of Bruton Memorial Library on June 21 due to a possible ... often overlooked aspect of head lice: the parasite’s ability to live away from a human ... but a necessary one in the event that lice have simply gotten out of control. ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
Breaking Medicine News(10 mins):